Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Calabash nut kernel from Crescentia cujete contains flavonoid glucosides, phenylethanoid derivatives, and iridoid glycosides that demonstrate antioxidant and antimicrobial activities through efflux pump inhibition and enzyme targeting. The extract exhibits metformin-like glucose uptake mechanisms, achieving 65.107% uptake at 25 µg/mL in preliminary studies.
Reported Benefits (Provisional)
Origin & History
The Calabash Nut Kernel, derived from the Crescentia cujete tree, is native to the tropical and subtropical regions of Africa, the Caribbean, and South America. This nutrient-dense kernel is prized for its contributions to cardiovascular health, cognitive function, and metabolic efficiency.
Research Narrative (Provisional)
Emerging research on Calabash Nut Kernel highlights its rich profile of unsaturated fats, tocopherols, and polyphenols, suggesting benefits for cardiovascular health, cognitive function, and detoxification. Studies often focus on its antioxidant, anti-inflammatory, and neuroprotective properties, with further human clinical trials needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Unsaturated Fats (Oleic Acid, Linoleic Acid) - Vitamin E (Tocopherols) - Minerals: Magnesium, Phosphorus, Zinc - Phytochemicals: Polyphenols (Flavonoids, Tannins), Plant Sterols
Reported Mechanism (Provisional)
Calabash nut kernel's flavonols and tannins inhibit bacterial efflux pumps while coumarins target DNA gyrase enzymes. The phenylethanoid derivatives facilitate membrane disruption and protein binding through hydrogen bonding interactions. Methanolic extracts demonstrate glucose uptake enhancement via metformin-like pathways, improving cellular glucose utilization.
Clinical Narrative (Provisional)
Current research on Crescentia cujete focuses primarily on in vitro and animal studies rather than human clinical trials. One animal safety study showed methanolic extracts caused no mortality in rats at doses exceeding 1,000 mg/kg, indicating potential safety at therapeutic levels. Laboratory studies demonstrate glucose uptake of 65.107% at 25 µg/mL, surpassing metformin controls, though human efficacy data remains limited. Further clinical trials are needed to establish therapeutic dosing and validate bioactivity in human subjects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.